中国血液净化 ›› 2018, Vol. 17 ›› Issue (11): 753-756.doi: 10.3969/j.issn.1671-4091.2018.11.008

• 血管通路 • 上一篇    下一篇

长期血液透析通路的介入治疗

吕佳璇1,李月红1   

  1. 1. 北京清华长庚医院肾内科
  • 收稿日期:2018-03-19 修回日期:2018-05-01 出版日期:2018-11-12 发布日期:2018-11-13
  • 通讯作者: 李月红:liyuehong0616@163.com E-mail:liyuehong0616@163.com

Endovascular intervention on long-term arteriovenous access

  • Received:2018-03-19 Revised:2018-05-01 Online:2018-11-12 Published:2018-11-13
  • Contact: Yuehong LI E-mail:liyuehong0616@163.com

摘要: 【摘要】血液透析是终末期肾病患者的主要治疗方式。经皮介入治疗可用于静脉或动脉狭窄导致的通路功能不良或失功,具有创伤小、失血少、保留有限血管资源等优势。经皮腔内血管成形术是多数透析通路病变的初始标准治疗方法,经皮血管支架植入术在处理中心静脉狭窄上具有优势。及早干预对延长通路使用寿命、提高患者生存质量有重要意义。

关键词: 透析通路, 经皮腔内血管成形术, 经皮血管支架植入术

Abstract: 【Abstract】Hemodialysis is the main renal replacement therapy for patients with end-stage renal disease. Complications of long-term arteriovenous access are the main reason for hospitalization in hemodialysis patients. Percutaneous interventional therapy can be used in poor function or failure of the arteriovenous access due to vein or arterial stenosis, which has the advantages of few trauma and blood loss and retention of limited blood vessel resources. Percutaneous transluminal angioplasty is the initial standard treatment for most dialysis pathway lesions. Percutaneous transluminal stenting has the advantages in dealing with central venous stenosis. Early intervention on malfunctional arteriovenous access is essential for extending the service life of arteriovenous access and improving patients’quality of life.

Key words: Arteriovenous access, Percutaneous transluminal angioplasty (PTA), Percutaneous transluminal stenting